Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.

about

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.

Item

http://www.wikidata.org/entity/Q45323547

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Timing of Hepatitis C Virus Tr ...... irect-acting Antiviral Agents.

@en

Timing of Hepatitis C Virus Tr ...... irect-acting Antiviral Agents.

@nl

type

Item

label

Timing of Hepatitis C Virus Tr ...... irect-acting Antiviral Agents.

@en

Timing of Hepatitis C Virus Tr ...... irect-acting Antiviral Agents.

@nl

prefLabel

Timing of Hepatitis C Virus Tr ...... irect-acting Antiviral Agents.

@en

Timing of Hepatitis C Virus Tr ...... irect-acting Antiviral Agents.

@nl

P1476

Timing of Hepatitis C Virus Tr ...... irect-acting Antiviral Agents.

@en

P2093

Aijaz Ahmed

http://www.w3.org/2001/XMLSchema#string

Andy Liu

http://www.w3.org/2001/XMLSchema#string

Aparna Goel

http://www.w3.org/2001/XMLSchema#string

Brandon J Perumpail

http://www.w3.org/2001/XMLSchema#string

Eric R Yoo

http://www.w3.org/2001/XMLSchema#string

George Cholankeril

http://www.w3.org/2001/XMLSchema#string

Mairin Joseph-Talreja

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

Liver transplantation for viral hepatitis in 2015

A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation.

Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation.

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

P304

363-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.14218/JCTH.2017.00007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29226102

http://www.w3.org/2001/XMLSchema#string

P932

5719193

http://www.w3.org/2001/XMLSchema#string